Elevated plasma levels of Nt-proBNP in patients with type 2 diabetes without overt cardiovascular disease.
about
Correlation between brain natriuretic peptide levels and the prognosis of patients with left ventricular diastolic dysfunctionBrain natriuretic peptide is related to diastolic dysfunction whereas urinary albumin excretion rate is related to left ventricular mass in asymptomatic type 2 diabetes patients.Prognostic value of brain natriuretic peptide in patients with heart failure and reserved left ventricular systolic function.Neurohormonal profile of patients with heart failure and diabetesN-terminal fragment of probrain natriuretic peptide is associated with diabetes microvascular complications in type 2 diabetes.Association of N-terminal pro-brain natriuretic peptide with cognitive function and depression in elderly people with type 2 diabetes.The biological variation of N-terminal pro-brain natriuretic peptide in postmenopausal women with type 2 diabetes: a case control study.N-Terminal Pro-B-type Natriuretic Peptide Levels in the Korean General PopulationN-terminal-pro-brain natriuretic peptide is decreased in insulin dependent gestational diabetes mellitus: a prospective cohort trial.Atrial natriuretic peptide and type 2 diabetes development--biomarker and genotype association study.N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) and Risk of Hypertension in the Atherosclerosis Risk in Communities (ARIC) Study.Evaluation of N-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein relationship with features of metabolic syndrome in high-risk subgroups for cardiovascular disease.Plasma NT-proBNP and white matter hyperintensities in type 2 diabetic patientsImpact of the look AHEAD intervention on NT-pro brain natriuretic peptide in overweight and obese adults with diabetes.Early detection and significance of structural cardiovascular abnormalities in patients with Type 2 diabetes mellitus.Clinical and subclinical macrovascular disease as predictors of cognitive decline in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.Natriuretic peptide testing in primary care patients.The activity of circulating dipeptidyl peptidase-4 is associated with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus.The Effect of Amlodipine and Sildenafil on the NT-ProBNP Level of Patients with COPD-Induced Pulmonary Hypertension.Review on natriuretic peptides: where we are, where we are going.Assessment and management of left ventricular hypertrophy in Type 2 diabetes patients with high blood pressure.Natriuretic Peptide System Activation in Acute Heart Failure Patients with DiabetesUtility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department.Slightly elevated B-type natriuretic peptide levels in a non-heart failure range indicate a worse left ventricular diastolic function in individuals with, as compared with individuals without, type 2 diabetes: the Hoorn Study.Impaired diastolic function and elevated Nt-proBNP levels in type 1 diabetic patients without overt cardiovascular disease.Medical costs in patients with heart failure after acute heart failure events: one-year follow-up study.N-terminal pro brain natriuretic peptide reflects long-term complications in type 1 diabetes.Association between the T-381C polymorphism of the brain natriuretic peptide gene and risk of type 2 diabetes in human populations.Age and gender differences in the association between Nt-proBNP and glucometabolic disturbances.Non-cardiac determinants of NT-proBNP levels in the elderly: relevance of haematocrit and hepatic steatosis
P2860
Q28601952-0C66601E-E304-4B90-B24A-39B6FFB02454Q33634605-A7CC3A6C-ACA1-4A9F-A6C5-966C992FF6DFQ33706264-7AE613C7-CB01-44DF-9A9D-F3DF1F4D9796Q33799053-13740BC3-0735-4107-B805-BD357B1A1EA1Q34351254-43DC89A0-3982-4654-B537-0BDFF0F49DAFQ34413727-1709BC91-2200-4E75-99E0-77B298719011Q34477250-8A0146F1-7E35-4751-9755-6C38CC19C0BBQ34512556-B4A248CB-002E-4504-9CAA-804E69B20106Q34871241-B48B538F-1306-426F-B947-478935902CE9Q35106848-C195A160-8F0A-4D7A-B458-A126251EBB37Q36087146-C7982642-CFEC-4297-9E0D-E6A83734F210Q36163932-A355B43C-1424-4786-8A75-A5B911512EC5Q36416295-8853699D-B014-47A4-AE9B-7B736D92FECBQ36433506-79253AC8-52AE-498C-9768-9CA0A90DA1DCQ37038967-FFA23958-AE63-4B07-9F76-41AB7CA9D889Q37106524-25E09B89-07C4-433F-85D5-A353D219FAA9Q37291305-E614DDE1-73FF-44C6-9812-332513539C03Q37366826-7BB9619C-BCE3-4BDE-A50B-59530CF9F8D4Q37687190-9610FCA5-07B6-4091-B5A2-457BAE0FD200Q38089931-77919A76-AB3D-4091-AB12-B5053818FDD4Q38113247-8B09543F-B7B5-4E01-97E2-D19D5E168307Q41448269-A947D451-6BF5-4703-8824-5A1A52DF698AQ42563345-B9044598-4763-4AD6-B6B5-E40E5251751BQ42953407-701489CF-56AE-4D02-99B8-44704255F706Q43859755-5CB6C5CB-846D-4928-BA76-B2EFD0E813ADQ47619118-70CF5B53-C6D6-4D59-94A2-3D27D396A71AQ48153777-18963AB1-1BC8-49FE-A2BB-B59F39D10D6AQ48215235-F89DE8D2-4DC0-4582-91E9-D3FF5B990A02Q51372983-BAC83A2D-0E07-437C-BE4A-ED4599DDF37FQ56997608-05703A0C-FA2B-4B9C-A4B6-CE159B137708
P2860
Elevated plasma levels of Nt-proBNP in patients with type 2 diabetes without overt cardiovascular disease.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Elevated plasma levels of Nt-p ...... overt cardiovascular disease.
@en
Elevated plasma levels of Nt-p ...... overt cardiovascular disease.
@nl
type
label
Elevated plasma levels of Nt-p ...... overt cardiovascular disease.
@en
Elevated plasma levels of Nt-p ...... overt cardiovascular disease.
@nl
prefLabel
Elevated plasma levels of Nt-p ...... overt cardiovascular disease.
@en
Elevated plasma levels of Nt-p ...... overt cardiovascular disease.
@nl
P2093
P921
P1433
P1476
Elevated plasma levels of Nt-p ...... overt cardiovascular disease.
@en
P2093
Anders Grubb
Bo Israelsson
Martin Magnusson
Stefan Jovinge
P304
P356
10.2337/DIACARE.27.8.1929
P407
P577
2004-08-01T00:00:00Z